An NHS spinout is aiming to put leading Scottish innovation in stroke treatment on the international map as it showcases its breakthrough technology in San Francisco this week. Biopharmaceutical company Aurum Biosciences is taking part in the flagship JP Morgan (JPM) Healthcare Week in San Francisco
Aurum Biosciences
1-2 of 2 Articles
Scottish biopharmaceutical firm Aurum Biosciences has successfully raised nearly £730,000 in the initial phase of its latest equity funding for advancing its state-of-the-art therapeutic and diagnostic technology. The funding round – which will be split across two tranches – has be

